Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

COLL

Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:COLL
DateTimeSourceHeadlineSymbolCompany
01/10/20253:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
01/08/20257:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
01/08/20257:00AMGlobeNewswire Inc.Collegium Provides 2025 Financial Guidance and Business UpdateNASDAQ:COLLCollegium Pharmaceutical Inc
11/14/20243:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
11/14/20243:49PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
11/12/20247:00AMGlobeNewswire Inc.Collegium to Participate in Upcoming Investor ConferencesNASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20243:02PMGlobeNewswire Inc.Collegium Reports Record Third Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20243:01PMGlobeNewswire Inc.Collegium Appoints Vikram Karnani as Chief Executive OfficerNASDAQ:COLLCollegium Pharmaceutical Inc
10/24/20247:00AMGlobeNewswire Inc.Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
09/17/20243:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/13/20249:39AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/13/20249:06AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/06/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/06/202410:53AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/05/20243:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/04/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
08/30/20247:00AMGlobeNewswire Inc.Collegium to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
08/28/20247:00AMGlobeNewswire Inc.Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024NASDAQ:COLLCollegium Pharmaceutical Inc
08/15/20243:05PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:COLLCollegium Pharmaceutical Inc
08/12/20241:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
08/09/20243:34PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
08/08/20243:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
08/08/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
08/08/20243:01PMGlobeNewswire Inc.Collegium Reports Second Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
07/29/20245:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
07/29/20245:00AMGlobeNewswire Inc.Collegium to Acquire Ironshore Therapeutics, Expanding into NeurologyNASDAQ:COLLCollegium Pharmaceutical Inc
07/25/20247:00AMGlobeNewswire Inc.Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
06/13/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:COLL